Changes in uveitis treatment during the pandemic may increase risk of relapse

This multicenter, prospective case series evaluated changes in ongoing immunomodulatory and biologic therapies used for noninfectious uveitis during the COVID-19 pandemic.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553